208.69MMarket Cap
LossP/E TTM
Voyager Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Voyager Therapeutics Inc is 7.42, ranking 231 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.91, which is -1812.45% below the recent high of 32.73 and -3046.67% above the recent low of -60.14.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.